ENDRA Life Sciences's total assets for Q3 2024 were $8.38M, a decrease of -19.76% from the previous quarter. NDRA total liabilities were $1.77M for the fiscal quarter, a 22.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.